Hydrazine hydrate (1:1) → HCID 10790603, compound
Reaction equation
[Br:1][C:2]1[N:6]2[CH:7]=[CH:8][CH:9]=[C:10]([O:11][CH2:12][C:13]3[C:18]([Cl:19])=[CH:17][CH:16]=[C:15]([N:20]([CH3:35])[C:21](=[O:34])[CH2:22][N:23]4C(=O)C5=CC=CC=C5C4=O)[C:14]=3[Cl:36])[C:5]2=[N:4][C:3]=1[CH3:37].O.NN>CO>[NH2:23][CH2:22][C:21]([N:20]([C:15]1[C:14]([Cl:36])=[C:13]([C:18]([Cl:19])=[CH:17][CH:16]=1)[CH2:12][O:11][C:10]1[C:5]2[N:6]([C:2]([Br:1])=[C:3]([CH3:37])[N:4]=2)[CH:7]=[CH:8][CH:9]=1)[CH3:35])=[O:34]Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
A mixture of 3-bromo-8-[2,6-dichloro-3-(N-methyl-N-phthalimidoacetylamino)benzyloxy]-2-methylimidazo[1,2-a]pyridine (450 mg) and hydrazine hydrate (41 mg) in methanol (5 ml) were refluxed for 30 minutes, and hydrazine hydrate (41 mg) was added thereto, and further, the mixture was refluxed for 1.5 hours. The resulting precipitates were filtered off and the filtrate was concentrated in vacuo. The residue was dissolved in chloroform and the solution was washed with water twice and brine, dried over magnesium sulfate and concentrated in vacuo. The residue was crystallized with diethyl ether to give 8-[3-(N-glycyl-N-methylamino)-2,6-dichlorobenzyloxy]-3-bromo-2-methylimidazo[1,2-a]pyridine (338 mg).
Workup
- temperaturewere refluxed for 30 minutes
- temperaturefurther, the mixture was refluxed for 1.5 hours
- customThe resulting precipitates
- filtrationwere filtered off
- concentrationthe filtrate was concentrated in vacuo
- dissolutionThe residue was dissolved in chloroform
- washthe solution was washed with water twice
- dry with materialbrine, dried over magnesium sulfate
- concentrationconcentrated in vacuo
- customThe residue was crystallized with diethyl ether
Sources & evidence
- ORD record
- ord-99323d1f36a14dffabf0e3239ce0ace2
- Source dataset
- uspto-grants-1998_05
- Patent number
- US05750699
Reaction notes
Loading…